Who
Habib J. Dable
Director
Company insider
Files Form 4 as: Director, PepGen; Director, Relay Therapeutics; Director, Day One Biopharmaceuticals; Director, Tyra Biosciences; Director, SpyGlass Pharma; Director, Blueprint Medicines; Director, Jade Biosciences; Director, Albireo Pharma.
In numbers
- Trades disclosed
- 106
- Buys
- 0
- Sells
- 9
- Bought
- $0
- Sold
- $19.6M
- Companies
- 10
- Companies where not an officer
- 9
- First trade
- 1 Dec 2016
- Last trade
- 18 Jun 2026
- Last filed
- 22 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Jun 2026filed 22 Jun 2026 | PEPG PepGenoption or derivative · Biotechnology | SEC FORM 4 Code A | —34,000 at $0.00 | filing |
| 18 Jun 2026filed 22 Jun 2026 | PEPG PepGenoption or derivative · Biotechnology | SEC FORM 4 Code A | —34,000 at $0.00 | filing |
| 9 Jun 2026filed 10 Jun 2026 | RLAY Relay Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —32,947 at $0.00 | filing |
| 9 Jun 2026filed 10 Jun 2026 | RLAY Relay Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —32,947 at $0.00 | filing |
| 23 Apr 2026filed 23 Apr 2026 | Day One Biopharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —66,660 | filing |
| 23 Apr 2026filed 23 Apr 2026 | Day One Biopharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —32,335 | filing |
| 23 Apr 2026filed 23 Apr 2026 | Day One Biopharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —22,500 | filing |
| 23 Apr 2026filed 23 Apr 2026 | Day One Biopharmaceuticalsoption or derivative | SEC FORM 4 Code D | —66,660 | filing |
| 23 Apr 2026filed 23 Apr 2026 | Day One Biopharmaceuticalsoption or derivative | SEC FORM 4 Code D | —32,335 | filing |
| 23 Apr 2026filed 23 Apr 2026 | Day One Biopharmaceuticalsoption or derivative | SEC FORM 4 Code D | —22,500 | filing |
| 23 Apr 2026filed 23 Apr 2026 | Day One Biopharmaceuticalsoption or derivative | SEC FORM 4 Code D | —15,000 | filing |
| 23 Apr 2026filed 23 Apr 2026 | Day One Biopharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —15,000 | filing |
| 16 Apr 2026filed 20 Apr 2026 | TYRA Tyra Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —44,400 at $0.00 | filing |
| 16 Apr 2026filed 20 Apr 2026 | TYRA Tyra Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —44,400 at $0.00 | filing |
| 5 Feb 2026filed 9 Feb 2026 | SGP SpyGlass Pharmaoption or derivative · Medical Devices | SEC FORM 4 Code A | —27,400 at $0.00 | filing |
| 5 Feb 2026filed 9 Feb 2026 | SGP SpyGlass Pharmaoption or derivative · Medical Devices | SEC FORM 4 Code A | —27,400 at $0.00 | filing |
| 6 Nov 2025filed 7 Nov 2025 | Day One Biopharmaceuticalsoption or derivative | SEC FORM 4 Code D | —66,660 at $0.00 | filing |
| 6 Nov 2025filed 7 Nov 2025 | Day One Biopharmaceuticalsoption or derivative | SEC FORM 4 Code A | —66,660 at $0.00 | filing |
| 6 Nov 2025filed 7 Nov 2025 | Day One Biopharmaceuticalsoption or derivative | SEC FORM 4 Code D | —32,335 at $0.00 | filing |
| 6 Nov 2025filed 7 Nov 2025 | Day One Biopharmaceuticalsoption or derivative | SEC FORM 4 Code A | —32,335 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
Related people
Nobody else traded the same names lately.